CN Patent

CN101309689A — 用于治疗糖尿病的二肽基肽酶抑制剂

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2008-11-19 · 17y expired

What this patent protects

提供了含有2－[[6－[(3R)－3－氨基－1－哌啶基]－3，4－二氢－3－甲基－2，4－二氧代－1(2H)－嘧啶基]甲基]－苄腈及其药学上可接受的盐的药物组合物，以及包含该药物组合物的药剂盒和制造品，以及使用该药物组合物的方法。

USPTO Abstract

提供了含有2－[[6－[(3R)－3－氨基－1－哌啶基]－3，4－二氢－3－甲基－2，4－二氧代－1(2H)－嘧啶基]甲基]－苄腈及其药学上可接受的盐的药物组合物，以及包含该药物组合物的药剂盒和制造品，以及使用该药物组合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101309689A
Jurisdiction
CN
Classification
—
Expires
2008-11-19
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.